You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adjuvant TMZ

Showing 1 - 25 of 4,704
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

6 Months Adjuvant Temozolomide vs No Adjuvant TMZ in Newly

Withdrawn
  • MGMT-Methylated Glioblastoma
  • Delay of TMZ
  • Standard of Care (SOC) Adjuvant TMZ (no intervention
  • (no location specified)
Aug 5, 2022

Glioblastoma Multiforme Trial in Montréal (Metformin)

Active, not recruiting
  • Glioblastoma Multiforme
  • Montréal, Quebec, Canada
    Montreal Neurological Institute - McGill University Health Centr
Aug 31, 2022

Glioblastoma, GBM Trial in Suzhou (XS005 Cell Injection, Temozolomide(TMZ))

Recruiting
  • Glioblastoma
  • GBM
  • Suzhou, Jiangsu, China
    Dushu Lake Hospital Affiliated to Soochow University
Nov 23, 2023

Glioblastoma Trial in Boston (radiation, biological, drug)

Recruiting
  • Glioblastoma
  • Radiation Therapy
  • +3 more
  • Boston, Massachusetts
  • +1 more
May 31, 2022

Glioblastoma Trial in Baltimore (Concurrent CRT Period, Post-CRT Period, Adjuvant Period)

Recruiting
  • Glioblastoma
  • Concurrent CRT Period
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University/Johns Hopkins Hospital
Mar 2, 2023

Glioblastoma, Glioblastoma, WHO Grade IV Trial in Gainesville (Temozolomide (TMZ), Optune System, Pembrolizumab)

Active, not recruiting
  • Glioblastoma
  • Glioblastoma, WHO Grade IV
  • Temozolomide (TMZ)
  • +2 more
  • Gainesville, Florida
    University of Florida Health
Aug 22, 2022

Glioblastoma Multiforme of Brain Trial in Beijing (Autologous dendritic cells pulsed with multiple neoantigen peptides.,

Recruiting
  • Glioblastoma Multiforme of Brain
  • Autologous dendritic cells pulsed with multiple neoantigen peptides.
  • Temozolomide adjuvant chemotherapy
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Jan 13, 2022

Glioblastoma Trial in Milwaukee (Radiation, Concurrent Chemotherapy (Temozolomide), Adjuvant Chemotherapy (Temozolomide))

Recruiting
  • Glioblastoma
  • Radiation
  • +2 more
  • Milwaukee, Wisconsin
    Medical College of Wisconsin
Jul 25, 2022

Astrocytoma, Grade II, Astrocytoma, Grade III Trial in United States (TTFields with adjuvant temozolomide)

Terminated
Has Results
  • Astrocytoma, Grade II
  • Astrocytoma, Grade III
  • TTFields with adjuvant temozolomide
  • Gainesville, Florida
  • +4 more
Aug 26, 2021

Glioblastoma, Gliosarcoma, Malignant Glioma Trial run by the NCI (TMZ, ipilimumab 3mg/kg, Nivolumab)

Recruiting
  • Glioblastoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

Primary Glioblastoma, Glioblastoma Multiforme Trial in Worldwide (2-OHOA, TMZ, RT)

Recruiting
  • Primary Glioblastoma
  • Glioblastoma Multiforme
  • Angers, France
  • +19 more
Dec 13, 2022

Glioblastoma Trial (Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide))

Not yet recruiting
  • Glioblastoma
  • Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide)
  • (no location specified)
Apr 20, 2022

Colorectal Cancer Trial (Irinotecan, Temozolomide)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Apr 1, 2022

Glioblastoma, Astrocytoma, Grade IV, Giant Cell Glioblastoma Trial in Durham (Unpulsed DCs, Td, Human CMV pp65-LAMP mRNA-pulsed

Completed
Has Results
  • Glioblastoma
  • +3 more
  • Unpulsed DCs
  • +6 more
  • Durham, North Carolina
    Duke University Medical Center
Jan 3, 2022

Glioblastoma, Gliosarcoma Trial in Houston (drug, radiation, procedure)

Recruiting
  • Glioblastoma
  • Gliosarcoma
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2022

Glioblastoma, IDH-wildtype, MGMT-Methylated Glioblastoma Trial in Padova (Regorafenib, Temozolomide)

Recruiting
  • Glioblastoma, IDH-wildtype
  • MGMT-Methylated Glioblastoma
  • Padova, Italy
    Istituto Oncologico Veneto IRCCS
Oct 18, 2023

Glioblastoma Trial in France (Intensified protocol, Stupp protocol)

Recruiting
  • Glioblastoma
  • Intensified protocol
  • Stupp protocol
  • Amiens, France
  • +18 more
Jul 19, 2022

Glioblastoma Multiforme Trial in Saint Louis (drug, procedure, radiation)

Active, not recruiting
  • Glioblastoma Multiforme
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 22, 2022

Metastatic Malignant Tumor in the Liver, Pancreatic Neuroendocrine Tumor, Stage I Pancreatic Neuroendocrine Tumor AJCC v8 Trial

Recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • +4 more
  • Ames, Iowa
  • +5 more
Dec 3, 2021

Glioblastoma, IDH-wildtype, Metformin, Malignancies Trial in Milan (Metformin)

Not yet recruiting
  • Glioblastoma, IDH-wildtype
  • +2 more
  • Milan, Italy
    Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Mil
Jun 26, 2023

Newly Diagnosed Glioblastoma Multiforme Trial (SI-053)

Not yet recruiting
  • Newly Diagnosed Glioblastoma Multiforme
  • (no location specified)
Apr 4, 2022

Glioblastoma Multiforme Trial in Calgary, Edmonton (Biomarker based treatment (Temozolomide monotherapy or Radiotherapy

Recruiting
  • Glioblastoma Multiforme
  • Biomarker based treatment (Temozolomide monotherapy or Radiotherapy monotherapy)
  • Chemo-Radiotherapy consisting of 40 Gy in 15 daily fractions with concurrent temozolomide.
  • Calgary, Alberta, Canada
  • +1 more
Jun 24, 2022

Grade III Astrocytoma, Grade IV Astrocytoma, Astrocytoma, Grade IV Trial in Saint Louis (Tadalafil)

Active, not recruiting
  • Grade III Astrocytoma
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 9, 2022

Glioblastoma Trial in Durham (Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF, Temozolomide, Tetanus-Diphtheria

Suspended
  • Glioblastoma
  • Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF
  • +4 more
  • Durham, North Carolina
    Duke University Medical Center
Aug 16, 2022

Glioblastoma Trial (PEP-CMV vaccine)

Not yet recruiting
  • Glioblastoma
  • PEP-CMV vaccine
  • (no location specified)
Nov 9, 2023